Source / episode info

• **Episode:**491
• **Title:**Divine Intervention Episode 491: USMLE Step 2/3 Rapid Review Series 106
• **Published:**2023-11-27
• Source:Episode page

One-liner

Episode 491 is a rapid review emphasizing critical multi-system processes: Tumor Lysis Syndrome (TLS) with electrolyte derangements; Spinal Cord Compression (SCC) management protocols; Superior Vena Cava Syndrome (SVC); and Colorectal Cancer workup/metastasis patterns.

High-yield summary

• Tumor Lysis Syndrome (TLS): Characterized by hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia due to massive cell death from malignancy or therapy; treatment requires aggressive hydration and urate-lowering agents (Luprioral, Rasburicase).
• Spinal Cord Compression (SCC): A medical emergency requiring immediate diagnosis via MRI. Initial management is always IV steroids, specifically Dexamethasone, followed by radiation or surgery.
• Superior Vena Cava Syndrome (SVC): Caused by external compression of the SVC (e.g., lung cancer, lymphoma); symptoms include facial/neck swelling and can cause signs mimicking heart failure (e.g., JVD).
• Colorectal Cancer Metastasis: The most common site of metastasis is the liver, due to the portal venous drainage system; multiple liver lesions are highly concerning for poor prognosis.
• 5-Fluorouracil (5-FU): A chemotherapy agent that works by inhibiting dihydrodipicolinate synthase, disrupting pyrimidine synthesis, and is commonly tested in board exams.

Learning objectives

• Differentiate the pathophysiology, clinical presentation, and initial management steps for Tumor Lysis Syndrome (TLS).
• Identify the classic signs and differential diagnoses associated with Spinal Cord Compression (SCC) and understand the acute treatment protocol.
• Recognize the causes and physical exam findings of Superior Vena Cava Syndrome (SVC) and its implications.
• Determine the most common site of metastasis for colorectal cancer and interpret clinical findings related to GI bleeding/anemia.
• Understand the mechanism of action and clinical use of key chemotherapeutic agents like 5-FU.

Board exam buzzwords